In clinical studies, the DR-70 immunoassay has been used to detect 14 types of cancer. At a specificity of 95%, the assay demonstrated sensitivities of 87.8% for lung cancer, 92.6% for gastric cancer, 65.2% for breast cancer, and 66.7% for colorectal cancer. Overall, DR-70 exhibited a specificity of 95.0% and a sensitivity of 83.8% for cancer detection.
Product Name: ELISA DR-70 Tumor Marker Diagnostic
Packaging: 96 reactions
Drug permit license: MOHW Pharmaceutical Manufacturing No. 004477
Note:For the specifications and contraindications of the product, please refer to the imitation list for details
